News
Displaying 121–130 of 504
-
Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
Research NewsThe company’s drug is designed to reduce accumulation of toxins that cause vision loss.
-
ProQR Seeking to Partner Ophthalmic Programs
Research NewsThe company is halting its clinical programs for LCA10 and USH2A as it seeks a new partner
-
Research News
Funding for the new grants was made possible by Foundation’s strong donor base and philanthropic partners
-
Progress toward a stem cell–based therapy for blindness
In the PressA multi-institutional effort led by researchers at the School of Veterinary Medicine is taking steps to develop an effective technique to regenerate photoreceptors cells and restore sight in people with vision disorders.
-
Research News
The emerging therapy is designed to restore vision for people with advanced retinal degenerative diseases
-
Apellis’ Treatment for Advanced Dry AMD to Receive Priority Review from FDA
Research NewsThere are currently no FDA-approved therapies for geographic atrophy (GA), the advanced form of dry AMD.
-
RD Fund Announces New Chair, and Expansion of Board of Directors
In the PressRD Fund Board member and seasoned ophthalmology leader Adrienne Graves, PhD, appointed chair. Ophthalmology luminaries Jean Bennett, MD, PhD, Catherine Bowes Rickman, PhD, and José-Alain Sahel, MD, to join the board.
-
Endogena Launches Clinical Trial of Therapy to Activate Stem Cells in RP Patients’ Retinas
Research NewsThe emerging treatment is gene-agnostic.
-
Kiora to Launch Clinical Trial in Australia for Vision-Restoring Small Molecule for RP Patients
Research NewsThe approach bestows light sensitivity to retinal ganglion cells for people who have lost their photoreceptors
-
Foundation Fighting Blindness Announces Leadership Changes
Foundation NewsJason Menzo named chief executive officer • Russell Kelley, PhD, MBA, appointed managing director of the RD Fund • Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company.
.png)
